SCHEMBL7804786

SCHEMBL7804786

COc1ccc(F)c2c(O)c3cnccc3cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.48
TDO2 P48775 6/20 0.42
IDO1 P14902 5/20 0.39
RPS6KA3 P51812 3/20 0.38
TRPA1 O75762 1/20 0.38
CYP3A4 P08684 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CASP1 P29466 1/20 0.37
CYP2C19 P33261 1/20 0.37
CASP7 P55210 1/20 0.37
HIF1A Q16665 1/20 0.37
MAPT P10636 1/20 0.37
CYP17A1 P05093 2/20 0.36
NQO1 P15559 1/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
ORAI1 Q96D31 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9826933 0.76 MAOA (0.63) MAOATDO2IDO1CYP3A4CYP1A2
SCHEMBL7811754 0.76 NQO1 (0.49) MAOATRPA1CYP3A4CYP1A2CYP2D6
SCHEMBL9826924 0.69 MAOA (0.61) MAOARPS6KA3CYP3A4MAPT
SCHEMBL9826844 0.67 MAOA (0.46) MAOARPS6KA3CYP3A4CYP1A2CASP1
SCHEMBL11176425 0.67 MAOA (0.58) MAOATDO2IDO1CYP3A4CYP1A2
SCHEMBL9826867 0.67 MAOA (0.46) MAOARPS6KA3CYP3A4CYP1A2CYP2D6
SCHEMBL9827753 0.67 DAO (0.44) MAOAMAPT
SCHEMBL12426316 0.67 MAOA (0.52) MAOAIDO1CYP1A2CYP2D6CYP2C9
SCHEMBL23940150 0.66 MAOA (0.43) MAOARPS6KA3CYP3A4MAPTCYP17A1
SCHEMBL29831723 0.65 MAOA (0.60) MAOAIDO1CYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed